Search research articles
Contact Us
Filters
Showing results (271-280 of 286) with videos related to
Page
of 29
Sort By:
Journal of Medicinal Chemistry
|
December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
Anthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Annals of Surgical Oncology
|
June 25, 2013
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States
K Turaga, E Levine, R Barone, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
Anthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
European Urology Oncology
|
May 20, 2026
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study
P Gontero, F Soria, M Babjuk, et al.
Annals of Surgical Oncology
|
October 31, 2006
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology
J Esquivel, R Sticca, P Sugarbaker, et al.
European Urology
|
January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology
|
February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology
|
November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus
|
May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology
|
January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 286) with videos related to
Sort By:
Page
of 29
Journal of Medicinal Chemistry
|
December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
Anthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Annals of Surgical Oncology
|
June 25, 2013
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States
K Turaga, E Levine, R Barone, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
Anthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
European Urology Oncology
|
May 20, 2026
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study
P Gontero, F Soria, M Babjuk, et al.
Annals of Surgical Oncology
|
October 31, 2006
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology
J Esquivel, R Sticca, P Sugarbaker, et al.
European Urology
|
January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
European Urology
|
February 25, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]
Richard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology
|
November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus
|
May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology
|
January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum
Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Page
of 29